ClinicalTrials.Veeva

Menu
R

RCMed | Sochaczew, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-7264
Gefapixant
Olokizumab
RGB-14-P
MK-7264-030
MK-7264-043
Evobrutinib
Pirepemat
ACU193
Prolia®

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 12 total trials

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants with Early Alzheimer's Disease (ALTITUDE-AD)

The primary purpose of this study is to evaluate the efficacy of sabirnetug infusions administered once every four weeks (Q4W) in slowing cognitive a...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: sabirnetug

Trial sponsors

Merck Sharp & Dohme (MSD) logo
R-Pharm logo
A
G
G
IBSA logo
I
Merck KGaA (EMD Serono) logo
Pfizer logo
Sandoz logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems